AR039460A1 - Factores camp quimericos - Google Patents

Factores camp quimericos

Info

Publication number
AR039460A1
AR039460A1 ARP030101452A ARP030101452A AR039460A1 AR 039460 A1 AR039460 A1 AR 039460A1 AR P030101452 A ARP030101452 A AR P030101452A AR P030101452 A ARP030101452 A AR P030101452A AR 039460 A1 AR039460 A1 AR 039460A1
Authority
AR
Argentina
Prior art keywords
camp
camp factor
chemical
uberis
factor
Prior art date
Application number
ARP030101452A
Other languages
English (en)
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of AR039460A1 publication Critical patent/AR039460A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Gen del factor CAMP de Streptococcus uberis (S. uberis), así como la producción recombinante del factor CAMP a partir del mismo. También se describen construcciones quiméricas del factor CAMP, inclusive epitopes del factor CAMP de más de una especie bacteriana. Los factores y las quimeras CAMP que incluyen los mismos se pueden usar composiciones inmunogénicas para la prevención y el tratamiento de infecciones bacterianas. también se describe vector, célula huésped, anticuerpos dirigidos contra el polipéptido inmunogénico y un conjunto de elementos de inmunodiagnóstico para detectar la infección por Streptococcus.
ARP030101452A 2002-04-26 2003-04-28 Factores camp quimericos AR039460A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/134,021 US6936259B2 (en) 1995-06-08 2002-04-26 CAMP factor of Streptococcus uberis

Publications (1)

Publication Number Publication Date
AR039460A1 true AR039460A1 (es) 2005-02-23

Family

ID=29268791

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101452A AR039460A1 (es) 2002-04-26 2003-04-28 Factores camp quimericos

Country Status (10)

Country Link
US (2) US6936259B2 (es)
EP (1) EP1499726A1 (es)
JP (1) JP2005523704A (es)
AR (1) AR039460A1 (es)
AU (1) AU2003229416B2 (es)
BR (1) BRPI0309570B1 (es)
CA (1) CA2483564A1 (es)
MX (1) MXPA04010646A (es)
NZ (2) NZ549506A (es)
WO (1) WO2003091437A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833134B2 (en) * 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
EP2189473A3 (en) * 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
AU2003260102A1 (en) * 2002-08-26 2004-03-11 Chiron Corporation Conserved and specific streptococcal genomes
PT1648500E (pt) * 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Composições imunogénicas para estreptococos piogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US7387883B2 (en) * 2003-12-09 2008-06-17 Biomerieux, Inc Methods for detecting bacterial pathogens
WO2006078318A2 (en) 2004-07-29 2006-07-27 Novartis Vaccines And Diagnostics Inc. Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
AU2005294275B2 (en) * 2004-10-08 2012-09-13 Glaxosmithkline Biologicals S.A. Immunogenic and therapeutic compositions for Streptococcus pyogenes
EP1904856A1 (en) * 2005-07-19 2008-04-02 Badrilla Limited Agents for and method of quantifying multiple related components in a biological system
CA2641064C (en) 2006-03-23 2017-03-07 Agriculture Victoria Services Pty Limited Antimicrobial protein
DK2054431T3 (da) * 2006-06-09 2012-01-02 Novartis Ag Konformere af bakterielle adhæsiner
US20110038879A1 (en) * 2006-10-30 2011-02-17 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
MX2009013269A (es) * 2007-06-05 2010-04-21 Univ Yale Inhibidores de receptor de cinasas de tirosina y metodos de uso de los mismos.
BRPI0816689B1 (pt) 2007-09-12 2021-08-24 Novartis Ag Composição de vacina, kit e método para a confecção de uma composição de vacina para a prevenção ou tratamento de infecção por streptococcus pyogenes
CN104292312A (zh) 2007-12-21 2015-01-21 诺华股份有限公司 链球菌溶血素o的突变形式
CA2718237C (en) * 2008-03-13 2017-12-05 Agriculture Victoria Services Pty Limited Vectors for expression of antimicrobial peptides in mammary gland
DK2668210T3 (da) 2011-01-26 2020-08-24 Celldex Therapeutics Inc Anti-kit antistoffer og anvendelser deraf
CA2880007C (en) 2012-07-25 2021-12-28 Kolltan Pharmaceuticals, Inc. Anti-kit antibodies and uses thereof
CN113908269A (zh) 2014-05-23 2022-01-11 塞尔德克斯医疗公司 嗜酸性粒细胞或肥大细胞相关病症的治疗
KR101712705B1 (ko) * 2014-08-19 2017-03-07 경북대학교 산학협력단 스트렙토코커스 애갈락티에 검출용 조성물 및 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
DK0626452T3 (da) 1993-05-17 2000-02-14 Akzo Nobel Nv Vaccine mod infektion af Streptococcus suis
AU709920B2 (en) 1995-06-08 1999-09-09 University Of Saskatchewan Camp factor of streptococcus uberis

Also Published As

Publication number Publication date
NZ536232A (en) 2006-12-22
EP1499726A1 (en) 2005-01-26
JP2005523704A (ja) 2005-08-11
US7700117B2 (en) 2010-04-20
NZ549506A (en) 2008-08-29
BRPI0309570B1 (pt) 2016-12-27
CA2483564A1 (en) 2003-11-06
AU2003229416A1 (en) 2003-11-10
US6936259B2 (en) 2005-08-30
US20030072765A1 (en) 2003-04-17
BR0309570A (pt) 2005-02-22
MXPA04010646A (es) 2005-02-17
WO2003091437A1 (en) 2003-11-06
US20040219639A1 (en) 2004-11-04
AU2003229416B2 (en) 2008-05-01

Similar Documents

Publication Publication Date Title
AR039460A1 (es) Factores camp quimericos
EP4272765A3 (en) Adeno-associated virus (aav) clade f vector and uses therefor
CY1121132T1 (el) ΠΛΗΡΩΣ-ΑΝΘΡΩΠΙΝΑ ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ANTI-vap-1
AR072695A2 (es) Proteinas insecticidas de bacillus thuringiensis
PE20091218A1 (es) Anticuerpo anti-glipicano 3 con cinetica en plasma mejorada
AR032231A1 (es) Nuevas proteinas insecticidas de bacillus thuringiensis
PE20060277A1 (es) Adenovirus quimericos en el tratamiento del cancer
PE20110310A1 (es) Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
NO20054405L (no) Kjemokinreseptor-binende heterosykel
EA201100070A1 (ru) Туберкулезный белок rv2386c, композиции и их применения
IL172506A0 (en) New biological entities and the use thereof
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
AR068428A1 (es) Secuencias peptidicas y composiciones que las comprenden que proveen proteccion contra enfermedades transmitidas por artropodos
ES2627117T3 (es) Método basado en MGMT para obtener un rendimiento elevado de expresión de proteínas recombinantes
MX2021000328A (es) Enzimas de variantes de galactosa oxidasa modificadas geneticamente.
ES2622087T3 (es) Vacuna recombinante contra paramyxovirus aviar y procedimiento de fabricación y utilización de la misma
AR100606A1 (es) Variantes de lipasas y polinucleótidos que las codifican
MX2021000322A (es) Enzimas de variante fosfopentomutasa modificada geneticamente.
ZA202107428B (en) Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof
BR112022025633A2 (pt) Adas compreendendo sistemas de secreção bacteriana
NO20060568L (no) Anvendelse av et nytt eimeriagen og tilhorende protein
CO6400229A2 (es) Construcciones de casb7439
WO2020207510A3 (zh) 基因在促进水稻籽粒产量上的应用

Legal Events

Date Code Title Description
FB Suspension of granting procedure